SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017299
Filing Date
2023-05-15
Accepted
2023-05-15 16:06:16
Documents
65
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 975136
2 ex31-1.htm EX-31.1 20487
3 ex31-2.htm EX-31.2 20501
4 ex32-1.htm EX-32.1 7962
5 ex32-2.htm EX-32.2 7981
6 form10-q_001.jpg GRAPHIC 7881
  Complete submission text file 0001493152-23-017299.txt   5406611

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mrzm-20230331.xsd EX-101.SCH 41602
8 XBRL CALCULATION FILE mrzm-20230331_cal.xml EX-101.CAL 48332
9 XBRL DEFINITION FILE mrzm-20230331_def.xml EX-101.DEF 190419
10 XBRL LABEL FILE mrzm-20230331_lab.xml EX-101.LAB 371895
11 XBRL PRESENTATION FILE mrzm-20230331_pre.xml EX-101.PRE 289322
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 766764
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53223 | Film No.: 23922075
SIC: 2834 Pharmaceutical Preparations